Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Irwin, R.
Right arrow Articles by French, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Irwin, R.
Right arrow Articles by French, C.

Chest, Vol 103, 1662-1669, Copyright © 1993 by American College of Chest Physicians


ARTICLES

Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol

RS Irwin, FJ Curley and CL French
Department of Medicine, University of Massachusetts Medical School, Worcester.

To our knowledge, there are no published results of protocols for managing difficult to control asthma (DTCA) or of the spectrum and frequencies of reasons why asthma can be difficult to control (DTC). To assess the usefulness of a systematic management protocol and determine the reason(s) why asthmatics are DTC, we developed a protocol that systematically considered multiple factors that may make asthma worse and prospectively evaluated the outcomes of therapeutic interventions for these factors and of inhaled corticosteroids (ICS) and azathioprine. We studied 42 consecutive and unselected DTCAs (19 men and 23 women) whose age was 48 +/- 15.9 years. They had a diagnosis of asthma for 15.1 +/- 15.8 years, were DTC for 4.8 +/- 7.8 years, and were followed up by us in the study for a total of 3.5 +/- 1.9 years. Initially, the dose of prednisone was 30.2 +/- 22 mg/d. Following utilization of the protocol, 74 percent were no longer DTC. It took 1.8 +/- 1.7 years for them to no longer be DTC; they remained so for 1.8 +/- 1.5 years. In these patients, 2.7 +/- 1.2 factors appeared to be responsible for the DTC state; 80 percent had > or = 2. Improvement was more likely if gastroesophageal reflux (GER) was a factor (p = 0.014); it correlated with the addition of ICS (p = 0.04) and treatment for GER (p = 0.02). Failure to reverse DTCA correlated with the suspicion (p = 0.004) and admission of nonadherence (p = 0.04). In 14 patients given azathioprine, prednisone dose decreased from 45 +/- 25.3 to 13.3 +/- 21.6 mg/d (p = 0.003); 6 of 14 achieved no longer DTC status; and substantial morbidity occurred. The reason(s) for DTCA could be determined in most instances by utilizing a systematic protocol; multiple factors were responsible in the majority of cases; treatment for GER and ICS were the two most helpful interventions; nonadherence was the most likely reason suspected for maintaining DTCA; and azathioprine acted as a corticosteroid-sparing agent that should not be prescribed routinely.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
T. O. Kiljander, S. M. Harding, S. K. Field, M. R. Stein, H. S. Nelson, J. Ekelund, M. Illueca, O. Beckman, and M. B. Sostek
Effects of Esomeprazole 40 mg Twice Daily on Asthma: A Randomized Placebo-controlled Trial
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1091 - 1097.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. E. Strek
Difficult asthma.
Proceedings of the ATS, January 1, 2006; 3(1): 116 - 123.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. ten Brinke, P. J. Sterk, A. A. M. Masclee, P. Spinhoven, J. T. Schmidt, A. H. Zwinderman, K. F. Rabe, and E. H. Bel
Risk factors of frequent exacerbations in difficult-to-treat asthma
Eur. Respir. J., November 1, 2005; 26(5): 812 - 818.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Jain
Proton-Pump Inhibitor Therapy for Gastroesophageal Reflux Disease: Does It Treat the Asthma?
Chest, April 1, 2005; 127(4): 1097 - 1098.
[Full Text] [PDF]


Home page
ChestHome page
J. J. Leggett, B. T. Johnston, M. Mills, J. Gamble, and L. G. Heaney
Prevalence of Gastroesophageal Reflux in Difficult Asthma: Relationship to Asthma Outcome
Chest, April 1, 2005; 127(4): 1227 - 1231.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
B D W Harrison
Difficult asthma
Thorax, July 1, 2003; 58(7): 555 - 556.
[Full Text] [PDF]


Home page
ThoraxHome page
L G Heaney, E Conway, C Kelly, B T Johnston, C English, M Stevenson, and J Gamble
Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol
Thorax, July 1, 2003; 58(7): 561 - 566.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. S. Irwin and J. M. Madison
The Persistently Troublesome Cough
Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1469 - 1474.
[Full Text] [PDF]


Home page
ChestHome page
S. K. Field
Asthma and Gastroesophageal Reflux : Another Piece in the Puzzle?
Chest, April 1, 2002; 121(4): 1024 - 1027.
[Full Text] [PDF]


Home page
ChestHome page
J. P. Lazenby, M. R. Guzzo, S. M. Harding, P. E. Patterson, L. F. Johnson, and L. A. Bradley
Oral Corticosteroids Increase Esophageal Acid Contact Times in Patients With Stable Asthma
Chest, February 1, 2002; 121(2): 625 - 634.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. D. Crowell, E. N. Zayat, B. E. Lacy, A. Schettler-Duncan, and M. C. Liu
The Effects of an Inhaled {beta}2-Adrenergic Agonist on Lower Esophageal Function : A Dose-Response Study
Chest, October 1, 2001; 120(4): 1184 - 1189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Wenzel
Proceedings of the ATS Workshop on Refractory Asthma . Current Understanding, Recommendations, and Unanswered Questions
Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2341 - 2351.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. M. HARDING, M. R. GUZZO, and J. E. RICHTER
The Prevalence of Gastroesophageal Reflux in Asthma Patients without Reflux Symptoms
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 34 - 39.
[Abstract] [Full Text]


Home page
ChestHome page
J. E. Richter
Asthma and Gastroesophageal Reflux Disease : The Truth Is Difficult to Define
Chest, November 1, 1999; 116(5): 1150 - 1152.
[Full Text] [PDF]


Home page
ChestHome page
T. O. Kiljander, E.-R. M. Salomaa, E. K. Hietanen, and E. O. Terho
Gastroesophageal Reflux in Asthmatics: A Double-Blind, Placebo-Controlled Crossover Study With Omeprazole
Chest, November 1, 1999; 116(5): 1257 - 1264.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. L. Emerman, P. G. Woodruff, R. K. Cydulka, M. A. Gibbs, C. V. Pollack Jr., and C. A. Camargo Jr.
Prospective Multicenter Study of Relapse Following Treatment for Acute Asthma Among Adults Presenting to the Emergency Department
Chest, April 1, 1999; 115(4): 919 - 927.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. M. Harding, M. R. Guzzo, and J. E. Richter
24-h Esophageal pH Testing in Asthmatics: Respiratory Symptom Correlation with Esophageal Acid Events
Chest, March 1, 1999; 115(3): 654 - 659.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. K. Field
A Critical Review of the Studies of the Effects of Simulated or Real Gastroesophageal Reflux on Pulmonary Function in Asthmatic Adults
Chest, March 1, 1999; 115(3): 848 - 856.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. K. FIELD, J. A. EVANS, and L. M. PRICE
The Effects of Acid Perfusion of the Esophagus on Ventilation and Respiratory Sensation
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1058 - 1062.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American College of Chest Physicians.